REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 4 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,614 | +81.5% | 44,593 | +55.9% | 0.16% | +52.9% |
| Q1 2023 | $119,876 | -18.2% | 28,610 | -17.1% | 0.10% | -19.4% |
| Q4 2022 | $146,625 | +205.5% | 34,500 | +15.0% | 0.13% | +111.5% |
| Q3 2022 | $48,000 | -98.0% | 30,000 | -92.8% | 0.06% | -86.9% |
| Q1 2021 | $2,402,000 | -23.3% | 418,437 | +16.8% | 0.47% | -22.3% |
| Q4 2020 | $3,133,000 | – | 358,300 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |